Skip to main content
. 2021 Nov 26;28(3):351–361. doi: 10.3350/cmh.2021.0281

Figure 1.

Figure 1.

Variables used in the risk prediction models for HCC in untreated or NA-treated CHB patients. There are differences in the variables used in the HCC prediction model depending on whether or not antiviral drugs are taken. CHB, chronic hepatitis B; HBV, hepatitis B virus; ALT, alanine aminotransferase; AFP, alpha-fetoprotein; NA, nucleos(t)ide analogues; γGT, gamma glutamyl transferase; COMP, cartilage oligomeric matrix protein; IL, interleukin; sPD1, serum programed death receptor 1; HCC, hepatocellular carcinoma.